Related Content
The true cost of manual HUB operations for specialty pharma manufacturers
Read More
For press and media inquiries, please contact:

How PAP automation lowers cost-per-patient-served for pharma manufacturers

Managing 100+ Authorization Rules Across Complex Payers

Patient assistance programs represent a significant commitment — financial and operational — for pharma manufacturers. Automation is the lever that determines whether that commitment reaches its full patient impact at a manageable cost or gets consumed by administrative overhead.

Patient assistance programs (PAP) exist because some patients cannot afford their medications, and pharma manufacturers have both a business interest and a responsibility to address that barrier. PAPs provide free or heavily subsidized drugs to qualifying uninsured or underinsured patients, representing a meaningful gross-to-net cost for manufacturers but also a genuine patient access benefit.

The challenge is operational. Running a PAP at scale — processing eligibility determinations, managing documentation, fulfilling products, tracking adherence — is complex and expensive. The administrative cost of a PAP can consume a disproportionate share of its total budget if the underlying processes are not built for efficiency. Automation changes this equation dramatically.

How PAP costs accumulate

The total cost of a patient assistance program has several components, not all of which are equally visible in budget planning:

  • Eligibility verification: determining whether each applicant meets income and insurance criteria requires documentation review and often interaction with the patient or their provider
  • Enrollment processing: the paperwork and data entry associated with enrolling a patient and initiating the program
  • Fulfillment: dispensing and shipping the product, which for specialty drugs often involves temperature-controlled handling and specialized pharmacy operations
  • Ongoing case management: monitoring patient status, managing renewals, handling appeals
  • Reporting and compliance: documenting program activity for regulatory and internal purposes

In a manual-first PAP operation, each of these steps requires significant staff time. As program volume grows, staffing costs grow proportionally — unless automation intercepts the routine work.

The CareTria PAP transformation

CareTria’s work with one of the industry’s largest pharma clients on PAP operations provides a concrete illustration of what is at stake. The client was experiencing backlogs in dispensing and enrollment, billing inaccuracies, and problems significant enough to require CEO-level attention. The situation was not unusual for a large PAP operating at volume without adequate automation and infrastructure.

CareTria’s intervention involved transferring nearly 17,000 active patients to a new operational infrastructure — a transition that required meticulous planning and flawless execution to avoid service disruption. The outcome was a 21% reduction in enrollment processing resulting in denials, significantly improved throughput speed, and a billing accuracy improvement that eliminated the escalation cycle.

17K Patients transferred without service disruption21% Reduction in enrollment denials post-transitionLower Cost-per-patient-served through automation

The mechanics of PAP automation

Effective PAP automation targets the highest-volume, most routine steps in the program workflow:

Digital enrollment and eligibility screening

Rather than manual review of paper applications, automated eligibility screening uses income databases and insurance verification systems to assess qualification quickly and consistently. Digital enrollment pathways — accessible to providers and patients online — eliminate the data entry burden and reduce processing time from days to hours.

Automated renewal management

PAP patients typically require annual re-enrollment. Automated renewal workflows — reminder communications, digital re-enrollment pathways, automated income re-verification — prevent the administrative bottleneck that would otherwise occur at renewal time and reduce the risk of coverage gaps for continuous-therapy patients.

Integrated fulfillment

Connecting PAP enrollment directly to pharmacy fulfillment systems — so that an approved enrollment triggers a dispensing order without manual data transfer — eliminates a common source of delay and error.

PAP automation and gross-to-net

PAP cost is a significant gross-to-net line for many specialty drug manufacturers. Automation lowers the administrative cost per patient served, which means the same PAP budget can reach more patients — improving both the access impact and the efficiency of the investment. For programs where the drug cost per patient is fixed, reducing administrative overhead is the primary lever available for improving program economics.

Managing a PAP with growing enrollment volume and rising administrative costs? CareTria’s automated PAP infrstructure reduces cost-per-patient-served while improving speed and accuracy. Talk to our team to learn more.

Share this page
Facebook
Twitter
LinkedIn
The true cost of manual HUB operations for specialty pharma manufacturers
The Pharma Manufacturer’s Guide to Choosing a Specialty 3PL Partner
PDMA compliance in pharma sample management: What you need to know